Claims for Patent: 4,780,408

Summary for Patent: 4,780,408

Title:	Antibody for detection and quantification of trifluralin
Abstract:	An antibody specific to trifluralin can be produced by first substituting a soluble, straight chain amino acid for a propyl group of .alpha.,.alpha., .alpha.-trifluoro-2,6-dinitro-N-N-dipropyl-p-toluidine. The trifluoro group at the 4 position, the nitro group at the 2 position and the other nitro group at the 6 position are left exposed. Thereafter, the resulting substitution product is conjugated, at the site of the substituted amino acid group, with a lysine-rich protein. The resulting compound is then used as an antigen to evoke an immune response in a host animal or antibody producing cell line. The antibody produced against the antigen is then harvested and used in an assay such as a radioimmunoassay or enzyme linked immunosorbant assay (ELISA) to determine the presence and concentrations of trifluralin in agriculturally significant substances such as plant materials, soil and water or to otherwise test for trifluralin contamination of water, food and air.
Inventor(s):	Dunbar; Bohn D. (Akron, CO), Niswender; Gordon D. (Fort Collins, CO), Hudson; James M. (Fort Collins, CO)
Assignee:	Colorado State University Research Foundation (Fort Collins, CO)
Application Number:	06/844,338
Patent Claims:	1. An antibody for an immunoassay for trifluralin, said antibody made by a process comprising: substituting a soluble, straight chain amino acid having at least one carbon atom for a propyl group of .alpha., .alpha., .alpha.-trifluoro-2-6-dinitro-N-N-dipropyl-p-tuluidine such that the trifluouro group at the 4 position, the nitro group at the 2 position and the other nitro group at the 6 position are left exposed to produce a resulting substitution product; conjugating the resulting substitution product, at the site of the amino acid, with a lysine-rich protein to produce an antigen; inoculating a host antibody producing biological system with the antigen to elicit production of an antibody specific to trifluralin; and harvesting the antibody specific to trifluralin form the host antibody producing biological system. 2. The antibody of claim 1 wherein the conjugation of the resulting substitution product with a lysine-rich protein is carried out using a mixed anhydride method. 3. The antibody of claim 1 wherein the soluble, straight chain amino acid has between one and about fourteen carbon atoms. 4. The antibody of claim 1 wherein the lysine-rich protein is selected from the group consisting of bovine serum albumin, ovalbumin, rabbit albumin, human serum albumin, thyroglobulin and fibrinogen. 5. An antibody for an immunoassay for trifluralin, said antibody made by process comprising: substituting a soluble, straight chain amino acid having at least one carbon atom for a propyl group of 3,5-dinitro-4(.beta.-propylaminopropionic acid)--benzotrifluoride such that the trifluoro group at the 4 position, the nitro group at the 2 position and the other nitro group at the 6 position are left exposed to produce a resulting substitution product; conjugating the resulting substitution product, at the site of the amino acid, with a lysine-rich protein to produce an antigen; inoculating a host antibody producing biological system with the antigen to elicit production of an antibody specific to trifluralin; and harvesting the antibody specific to trifluralin from the host antibody producing biological system. 6. The antibody of claim 5 wherein the conjugation of the resulting substitution product with a lysine-rich protein is carried out using a mixed anyhdride method. 7. The antibody of claim 5 wherein the soluble, straight chain amino acid has between one and about fourteen carbon atoms. 8. The antibody of claim 5 wherein the lysine-rich protein is selected from the group consisting of bovine serum albumin, ovalbumin, rabbit serum albumin, human serum albumin, thyroglobulin and fibrinogen. 9. In an immunoassay for the detection of trifluralin comprising: a. providing a sample suspected of containing trifluralin; b. contacting an antibody with the sample; c. detecting the presence of a reaction between the antibody and said sample wherein the presence of a reation is an indication of the presence of trifluralin and no reaction indicates no trifluralin is present wherein the improvement comprises employing the antibody of claim 1. 10. The method of claim 9 wherein the conjugation of the substitution product, at the site of the amino acid, is carried out using a mixed anhydride method; the soluble, straight chain amino acid has between one and about fourteen carbon atoms; the lysine-rich protein is selected from the group consisting of bovine serum albumin, ovalbumin, rabbit serum albumin, human serum albumin, thyroglobulin and fibrinogen and the immunoassay is based upon the ability of the antibody to selectively bind with trifluralin. 11. In an immunoassay for the detection of trifluralin comprising: a. providing a sample suspected of containing trifluralin; b. contacting an antibody with the sample; c. detecting the presence of a reaction between the antibody and said sample wherein the presence of a reaction is an indication of the presence of trifluralin and no reaction indicates no trifluralin is present wherein the improvement comprises employing the antibody of claim 5. 12. The method of claim 11 wherein the conjugation of the substitution product, at the site of the amino acid, is carried out using a mixed anhydride method; the soluble, straight chain amino acid has between two and about fourteen carbon atoms; the lysine-rich protein is selected from the group consisting of bovine serum albumin, ovalbumin, rabbit serum albumin, human serum olbumin, thyroglobulin and fibrinogen and the immunoassay is based upon the ability of the anitbody to selectively bind with trifluralin.

Details for Patent 4,780,408

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Grifols Therapeutics Llc	ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5	albumin (human)	For Injection	101138	10/21/1942		2040-01-28
Baxalta Us Inc.	BUMINATE, FLEXBUMIN	albumin (human)	Injection	101452	03/03/1954		2040-01-28
Csl Behring Ag	ALBURX	albumin (human)	Injection	102366	07/23/1976		2040-01-28
Grifols Biologicals Llc	ALBUTEIN	albumin (human)	Injection	102478	08/15/1978		2040-01-28
Instituto Grifols, S.a.	HUMAN ALBUMIN GRIFOLS	albumin (human)	Injection	103352	02/17/1995		2040-01-28
Instituto Grifols, S.a.	HUMAN ALBUMIN GRIFOLS	albumin (human)	Injection	103352	06/11/2003		2040-01-28